• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    8.13 Down 0.04(0.49%) Feb 27, 4:00PM EST
    |After Hours : 8.13 0.00 (0.00%) Feb 27, 5:34PM EST
    Add to Portfolio
    Prev Close:8.17
    Open:8.18
    Bid:8.13 x 100
    Ask:N/A
    1y Target Est:8.67
    Beta:0.82
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:8.05 - 8.35
    52wk Range:4.90 - 8.85
    Volume:4,915,815
    Avg Vol (3m):6,485,890
    Market Cap:1.52B
    P/E (ttm):N/A
    EPS (ttm):-0.87
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARIADown 0.49%1.52B
    NVSDown 0.58%245.62B
    PFEDown 0.78%216.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.01
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback